Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Stock
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
22.1M
-
Shares change
-
-1.12M
-
Total reported value, excl. options
-
$20.3M
-
Value change
-
-$802K
-
Put/Call ratio
-
0.04
-
Number of buys
-
15
-
Number of sells
-
-20
-
Price
-
$0.92
Significant Holders of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) as of Q1 2024
57 filings reported holding CDTX - CIDARA THERAPEUTICS INC COM NEW - Stock as of Q1 2024.
CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.1M shares
.
Largest 10 shareholders include BVF INC/IL (6.86M shares), VANGUARD GROUP INC (3.35M shares), RENAISSANCE TECHNOLOGIES LLC (2.55M shares), ALETHEA CAPITAL MANAGEMENT, LLC (1.6M shares), Point72 Asset Management, L.P. (1.25M shares), 5AM Venture Management, LLC (1.13M shares), GEODE CAPITAL MANAGEMENT, LLC (838K shares), BlackRock Inc. (715K shares), Schonfeld Strategic Advisors LLC (552K shares), and GSA CAPITAL PARTNERS LLP (457K shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.